{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:30:35Z","timestamp":1781915435429,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102178","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:06:14Z","timestamp":1766592374000},"page":"102178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Telemedicine and hybrid engagement models facilitate hepatitis C cascade of care during periods of healthcare disruption"],"prefix":"10.1016","volume":"31","author":[{"given":"Sabrina","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Imsirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3368-3499","authenticated-orcid":false,"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.aohep.2025.102178_bib0001","article-title":"Chronic Hepatitis C: pathophysiology and Clinical issues","author":"Abate","year":"2022","journal-title":"Biology (Basel)"},{"issue":"24","key":"10.1016\/j.aohep.2025.102178_bib0002","article-title":"Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: insight into a low-risk undiagnosed population","author":"O'Brien","year":"2024","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.aohep.2025.102178_bib0003","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"48","key":"10.1016\/j.aohep.2025.102178_bib0004","article-title":"National Hepatitis C estimates: incidence, prevalence, undiagnosed proportion and treatment, Canada","volume":"2022","author":"Popovic","year":"2019","journal-title":"Can Commun Dis Rep"},{"issue":"47","key":"10.1016\/j.aohep.2025.102178_bib0005","article-title":"The hepatitis C epidemic in Canada: an overview of recent trends in surveillance, injection drug use, harm reduction and treatment","author":"Lourenco","year":"2021","journal-title":"Can Commun Dis Rep"},{"issue":"28","key":"10.1016\/j.aohep.2025.102178_bib0006","article-title":"Burden of disease and cost of chronic hepatitis C infection in Canada","author":"Myers","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.102178_bib0007","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Available at: URL."},{"key":"10.1016\/j.aohep.2025.102178_bib0008","unstructured":"Public Health Agency of Canada. Reducing the health impact of sexually transmitted and blood-borne infections in Canada by 2030: a pan-Canadian STBBI framework for action. Government of Canada. Available at: URL."},{"key":"10.1016\/j.aohep.2025.102178_bib0009","unstructured":"World Health Organization. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Available at: URL."},{"issue":"32 Suppl 1","key":"10.1016\/j.aohep.2025.102178_bib0010","article-title":"Barriers to hepatitis C treatment","author":"McGowan","year":"2012","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.aohep.2025.102178_bib0011","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors","author":"Harris","year":"2013","journal-title":"Harm Reduct J"},{"issue":"49","key":"10.1016\/j.aohep.2025.102178_bib0012","article-title":"Hepatitis C treatment for injection drug users: a review of the available evidence","author":"Hellard","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.aohep.2025.102178_bib0013","article-title":"Telemedicine successfully engages marginalized rural hepatitis C patients in curative care","author":"Lepage","year":"2020","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"issue":"33","key":"10.1016\/j.aohep.2025.102178_bib0014","article-title":"Limited uptake of hepatitis C treatment among injection drug users","author":"Mehta","year":"2008","journal-title":"J Community Health"},{"issue":"4","key":"10.1016\/j.aohep.2025.102178_bib0015","article-title":"Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience","author":"Nguyen","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.aohep.2025.102178_bib0016","unstructured":"CanHepC. The Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups. Blueprint to Inform Hepatitis C Elimination Efforts in Canada. Available at: URL."},{"issue":"97","key":"10.1016\/j.aohep.2025.102178_bib0017","article-title":"Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montreal: results from three cross-sectional studies (2005, 2009, 2018)","author":"Laniece Delaunay","year":"2021","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.aohep.2025.102178_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8987976","article-title":"Distribution of Hepatitis C risk factors and HCV treatment outcomes among Central Canadian aboriginal","volume":"2016","author":"Parmar","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.102178_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/380963","article-title":"The epidemiology of hepatitis C in a Canadian indigenous population","volume":"27","author":"Uhanova","year":"2013","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102178_bib0020","article-title":"The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?","author":"Hoj","year":"2018","journal-title":"Can Liver J"},{"issue":"60","key":"10.1016\/j.aohep.2025.102178_bib0021","article-title":"Use of telemedicine technologies in the management of infectious diseases: a review","author":"Parmar","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.aohep.2025.102178_bib0022","article-title":"Direct-acting antiviral therapy outcomes in Canadian chronic Hepatitis C telemedicine patients","author":"Cooper","year":"2017","journal-title":"Ann Hepatol"},{"issue":"19","key":"10.1016\/j.aohep.2025.102178_bib0023","article-title":"Successful treatment of patients with hepatitis C in rural and remote Western Australia via telehealth","author":"Nazareth","year":"2013","journal-title":"J Telemed Telecare"},{"issue":"14","key":"10.1016\/j.aohep.2025.102178_bib0024","article-title":"The evaluation of patients with hepatitis C living in rural California via telemedicine","author":"Rossaro","year":"2008","journal-title":"Telemed J E Health"},{"issue":"18","key":"10.1016\/j.aohep.2025.102178_bib0025","article-title":"Evaluation of human immunodeficiency virus and hepatitis C telemedicine clinics","author":"Saifu","year":"2012","journal-title":"Am J Manag Care"},{"issue":"59","key":"10.1016\/j.aohep.2025.102178_bib0026","article-title":"Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: an observational study with historical controls","author":"Young","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.aohep.2025.102178_bib0027","article-title":"Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update","author":"Cooke","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.102178_bib0028","unstructured":"Public Health Agency of Canada. Survey of the impact of COVID-19 on the ability to provide STBBI prevention, testing and treatment including harm reduction services in Canada. Available at: URL."},{"issue":"19","key":"10.1016\/j.aohep.2025.102178_bib0029","article-title":"eHealth Technologies for screening, diagnosis, and management of viral Hepatitis: a systematic review","author":"Haridy","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.102178_bib0030","article-title":"Telehealth: mapping the evidence for patient outcomes from systematic reviews","author":"Totten","year":"2016","journal-title":"Rockville (MD),"},{"issue":"9","key":"10.1016\/j.aohep.2025.102178_bib0031","article-title":"The potential socio-economic impact of telemedicine in Canada","author":"Hafner","year":"2022","journal-title":"Rand Health Q"},{"issue":"242","key":"10.1016\/j.aohep.2025.102178_bib0032","article-title":"Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States","author":"Lin","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 2","key":"10.1016\/j.aohep.2025.102178_bib0033","article-title":"Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico","volume":"122","author":"Arora","year":"2007","journal-title":"Public Health Rep"},{"issue":"31","key":"10.1016\/j.aohep.2025.102178_bib0034","article-title":"A contactless cure: leveraging telehealth to improve hepatitis C treatment at a safety-net hospital","author":"Frye","year":"2024","journal-title":"J Viral Hepat"},{"issue":"26","key":"10.1016\/j.aohep.2025.102178_bib0035","article-title":"Show me ECHO-Hepatitis C: a telemedicine mentoring program for patients with hepatitis C in underserved and rural areas in Missouri as a model in developing countries","author":"Tahan","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.aohep.2025.102178_bib0036","unstructured":"Government of Ontario. Virtual Care 1: comprehensive and limited virtual care services. Available at: URL."},{"issue":"54","key":"10.1016\/j.aohep.2025.102178_bib0037","article-title":"Hepatitis C testing, status and treatment among marginalized people who use drugs in an inner City setting: an observational cohort study","author":"Boucher","year":"2019","journal-title":"Subst Use Misuse"},{"issue":"114","key":"10.1016\/j.aohep.2025.102178_bib0038","article-title":"Hepatitis C cascade of care at an integrated community facility for people who inject drugs","author":"Morris","year":"2020","journal-title":"J Subst Abuse Treat"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812500403X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812500403X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:50:13Z","timestamp":1780649413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812500403X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S166526812500403X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102178","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telemedicine and hybrid engagement models facilitate hepatitis C cascade of care during periods of healthcare disruption","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102178"}}